Research Studies

Interested in participating in research studies? Scroll down to browse our current list.

Drug

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease

Drug

A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to moderate Alzheimer's disease (GREEN MEMORY: GREen Valley 971 E

Drug

The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Drug

Escitalopram for Agitation in Alzheimer's Disease (S-citAD) Study at Ontario Shores

Drug

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease

Drug

A phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of AL002 in participants with Early Alzheimer's disease copy

Participate in Research through MINT Memory Clinic

Questions about MINT Clinic Research Match?

Contact us